(MedPage Today) — The age of type 2 diabetes patients may alter the level of cardioprotection from two newer classes of anti-diabetic agents, a network meta-analysis suggested.
The relative reduction in major adverse cardiovascular events (MACE…
Source link : https://www.medpagetoday.com/endocrinology/diabetes/114051
Author :
Publish date : 2025-02-03 18:31:02
Copyright for syndicated content belongs to the linked Source.
